CE Marking
EU MDR Regulatory Compliance
Classification, technical documentation and conformity assessment under Regulation (EU) 2017/745, through to your notified body review.
Applies to: Medical device manufacturers entering the EU market
What Is MDR and Why It Matters?
The EU MDR (Regulation (EU) 2017/745) establishes comprehensive requirements for placing medical devices on the European market. It strengthens clinical evidence, post-market surveillance, traceability, and transparency. MDR introduces stricter classification rules and expanded technical documentation requirements. Compliance is mandatory for CE marking of medical devices in the EU. It ensures higher patient safety and regulatory oversight across the product lifecycle.
How Can We Help?
MDR compliance is demanding, resource-intensive, and unforgiving. The expanded technical documentation, stricter clinical evaluation requirements, reclassification risks, and intensive notified body scrutiny make it one of the most challenging regulatory frameworks in the world. We take this complexity off your shoulders. Our team systematically analyzes your current documentation, identifies regulatory gaps, and builds a structured roadmap toward compliance. We redesign technical files, strengthen clinical evidence, align risk management, and implement robust post-market surveillance systems. By managing the process proactively and anticipating notified body expectations, we reduce delays, prevent costly rejections, and turn a complex regulatory burden into a controlled, achievable pathway to CE marking.
FAQ
EU MDR — frequently asked questions
The EU Medical Device Regulation (MDR) applies to medical devices, while the EU In Vitro Diagnostic Regulation (IVDR) applies specifically to in vitro diagnostic devices.
Yes. Devices previously certified under MDD or IVDD must transition to MDR or IVDR within defined timelines. Many devices now require reclassification, additional clinical data, and updated technical documentation.
- Because they significantly increase: Clinical evidence requirements
- Regulatory scrutiny by Notified Bodies
- Documentation depth and traceability
- Post-market surveillance obligations
Many manufacturers face delays or market withdrawal due to underestimating these changes.
Timelines depend on device classification, technical complexity, and documentation readiness. For MDR and IVDR projects, the most time-consuming factors are clinical or performance evidence, technical documentation completeness, and Notified Body availability. Poor preparation is the main reason projects exceed planned timelines.
Costs vary widely and depend on:
- Device classification and scope
- Clinical or performance study needs
- Notified Body involvement and fees
- Internal readiness and documentation quality
Unplanned rework, rejected submissions, and late-stage redesigns are the largest cost drivers.
Certilance supports manufacturers with MDR/IVDR gap analysis, quality management system alignment, technical file structuring, and Notified Body audit preparation which reduce approval risk and time to market.
EU MDR
Ready to start your EU MDR project?
Book a free consultation and we will map the gaps, the timeline and the cost before any work begins.